HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 216 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $104,087,780 | +24.2% | 2,724,811 | +17.3% | 0.21% | +28.7% |
| Q2 2023 | $83,809,476 | +146.7% | 2,323,523 | +161.2% | 0.16% | +127.8% |
| Q1 2023 | $33,976,382 | +596.5% | 889,667 | +702.5% | 0.07% | +620.0% |
| Q2 2022 | $4,878,000 | +3218.4% | 110,861 | +1232.9% | 0.01% | +900.0% |
| Q4 2019 | $147,000 | -98.3% | 8,317 | -98.4% | 0.00% | -98.6% |
| Q2 2019 | $8,815,000 | +495.6% | 513,083 | +458.3% | 0.07% | +942.9% |
| Q1 2019 | $1,480,000 | – | 91,894 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |